METHOD FOR TREATING TAXOL SIDE-EFFECTS WITH G-CSF Read more about METHOD FOR TREATING TAXOL SIDE-EFFECTS WITH G-CSF US Patent 5,496,804Filed on 1994-11-21
USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK Read more about USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK US Patent 5,700,830Filed on 1994-11-22
BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF.... Read more about BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF.... US Patent 5,632,981Filed on 1994-11-22
SELF-ASSEMBLING RECOMBINANT PAPILLOMAVIRUS CAPSID PROTEINS Read more about SELF-ASSEMBLING RECOMBINANT PAPILLOMAVIRUS CAPSID PROTEINS US Application 08/484,181Filed on 1995-06-07
HUMANIZED TUMOR-SPECIFIC ANTIBODY FRAGMENTS, FUSION PROTEINS, AND USES THEREOF Read more about HUMANIZED TUMOR-SPECIFIC ANTIBODY FRAGMENTS, FUSION PROTEINS, AND USES THEREOF US Patent 5,889,157Filed on 1994-10-28
CHIMERIC AND MUTATIONALLY STABILIZED TUMOR-SPECIFIC ANTIBODY FRAGMENT FUSION PROTEINS, AND USES THEREOF Read more about CHIMERIC AND MUTATIONALLY STABILIZED TUMOR-SPECIFIC ANTIBODY FRAGMENT FUSION PROTEINS, AND USES THEREOF US Patent 5,981,726Filed on 1994-10-28
SINGLE CHAIN B3 ANTIBODY FUSION PROTEINS AND THEIR USES Read more about SINGLE CHAIN B3 ANTIBODY FUSION PROTEINS AND THEIR USES US Patent 5,608,039Filed on 1994-10-28
Use of 8-C1-cAMP as Anticancer Drug Read more about Use of 8-C1-cAMP as Anticancer Drug US Patent 5,792,752Filed on 1994-10-27
Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof Read more about Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof US Patent 6,001,349Filed on 1995-02-22
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY Read more about USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY US Patent 6,040,334Filed on 1994-10-20